MARKET

HZNP

HZNP

Horizon Therapeutics Plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

31.37
-0.48
-1.51%
After Hours: 31.37 0 0.00% 16:41 04/03 EDT
OPEN
31.57
PREV CLOSE
31.85
HIGH
32.27
LOW
30.61
VOLUME
3.77M
TURNOVER
--
52 WEEK HIGH
39.10
52 WEEK LOW
22.69
MARKET CAP
5.97B
P/E (TTM)
15.44
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average HZNP stock price target is 44.40 with a high estimate of 50.00 and a low estimate of 38.00.

EPS

HZNP News

More
  • Should You Buy These 3 Biotechs Now?
  • MotleyFool.com · 2d ago
  • Horizon acquires Curzion Pharma for $45M
  • Seeking Alpha - Article · 3d ago
  • Morgan Stanley Maintains Overweight on Horizon Therapeutics, Lowers Price Target to $39
  • Benzinga · 3d ago
  • Horizon Therapeutics plc Acquires Curzion Pharmaceuticals, Inc. and Its LPAR1 Antagonist Product Candidate to Expand Development-Stage Pipeline
  • Business Wire · 3d ago

Industry

Pharmaceuticals
-0.14%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About HZNP

Horizon Therapeutics plc, formerly Horizon Pharma plc, is a rare disease biopharmaceutical company. The Company is focused on researching, developing and commercializing medicines that address needs for people impacted by rare and rheumatic diseases. The Company markets approximately 10 medicines, of which 6 are for rare and rheumatic diseases. The Company's marketed medicines are ACTIMMUNE (interferon gamma-1b), BUPHENYL (sodium phenylbutyrate) Tablets and Powder, DUEXIS (ibuprofen/famotidine), KRYSTEXXA (pegloticase), PENNSAID (diclofenac sodium topical solution) 2% weight per weight (w/w), or PENNSAID 2%, PROCYSBI (cysteamine bitartrate) delayed-release capsules, QUINSAIR (aerosolized form of levofloxacin), RAVICTI (glycerol phenylbutyrate) Oral Liquid, RAYOS (prednisone) delayed-release tablets and VIMOVO (naproxen/esomeprazole magnesium).
More

Webull offers kinds of Horizon Therapeutics PLC stock information, including NASDAQ:HZNP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HZNP stock news, and many more online research tools to help you make informed decisions.